Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11834493 Antibody cocktail against SARS-CoV-2 spike protein

Patent 11834493 was granted and assigned to Immunome Inc. on December, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Pavel Nikitin0

Matthew K. Robinson0

Michael John Morin0

John P. Dowling0

Jillian Dimuzio0

Ray Howanski0

Date of Patent

December 5, 2023

0

Patent Application Number

175685760

Date Filed

January 4, 2022

0

Patent Citations

US Patent 8999707 Method of making hybrid cells that express useful antibodies

0

US Patent 7491530 Fusion partner cells and uses thereof

0

US Patent 7566772 Antibodies against interleukin-1β

0

US Patent 8980268 Methods for treating cancer by administering an anti-Ang-2 antibody

0

US Patent 10787501 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

0

Patent Primary Examiner

Aurora M Fontainhas

0

CPC Code

0

0

0

0

0

Patent abstract

Provided herein are antibodies that are useful for treating SARS-CoV-2 infections in a subject. Also provided herein are compositions comprising one or more antibodies, methods of treatment comprising administering one or more antibodies, and kits comprising one or more antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11834493 Antibody cocktail against SARS-CoV-2 spike protein

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.